UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030974 |
|---|---|
| Receipt number | R000035326 |
| Scientific Title | An Open-label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma Initially Treated with an Injection of Proteasome Inhibitor-Based Therapy |
| Date of disclosure of the study information | 2018/01/24 |
| Last modified on | 2020/06/01 11:05:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/01/24 14:51:13 | ||
| 2 | Update | 2018/01/24 14:56:39 | Division name Address Division name Address |
|
| 3 | Update | 2018/01/24 14:58:27 | Division name Division name |
|
| 4 | Update | 2018/01/24 16:28:00 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 5 | Update | 2018/02/02 15:29:54 | Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
| 6 | Update | 2018/02/02 15:32:56 | Acronym Acronym |
|
| 7 | Update | 2018/03/01 11:33:20 | Last name of lead principal investigator |
|
| 8 | Update | 2018/03/01 11:34:18 | Anticipated trial start date |
|
| 9 | Update | 2018/03/14 09:13:23 | Recruitment status Anticipated trial start date |
|
| 10 | Update | 2018/07/18 10:08:28 | Last follow-up date |
|
| 11 | Update | 2019/03/07 10:41:16 | Address Address Division name Division name Address Address Organization1 Address1 |
|
| 12 | Update | 2020/06/01 11:05:40 | Recruitment status Date of IRB |
